CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
CLOVER HEALTH INVESTMENTS, CORP. /DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$4.44−0.04 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- –
- Dividend yield
- –
CLOVER HEALTH INVESTMENTS, CORP. /DE revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insurance segment | $25.26M | $20.35M | $13.77M | $5.38M | $16.22M | $14.45M | $120.00K | $1.87M | – | – | – | – | 3.4% | +55.7% |
| Insurance Segment | – | – | – | – | $16.22M | $14.45M | – | – | $1.06M | $914.00K | – | – | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Clover Health Investments's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.